Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Spirit Halloween CEO Reacts to SNL Skit and Why They Clapped Back
Spirit Halloween CEO, Steve Silverstein, stops by Cheddar to talk SNL, this year's top costume ideas and why you should watch out for Spirit Christmas. Watch!
Taxpayers In 24 States Can Now File Directly With The IRS Next Year
The IRS is expanding its program that allows people to file their taxes directly with the agency for free.
Big Business This Week: Robot Taxis and Flying Taxis
Oh, we're also on YouTube now.
Dog Tag Bakery Recruits Veterans
Washington DC based non-profit Dog Tag, explains how their business education programs are helping former service members re-enter the workforce.
Oil Prices Jump, Wall Street Jitters Over Israel’s Likely Iran Strike
Crude prices jumped on worries about worsening tensions in the Middle East, while U.S. stocks pulled back further from their records.
Brooks Introduces Latest In Running Tech
Brooks Running SVP of Footwear, Carson Caprara, introduces the new Glycerin Max and explains how leaning into innovation helps build customer brand loyalty
Tesla Shares Slump Despite Increase In Q3 Global Deliveries
Tesla shares were down 4% after improved Q3 delivery numbers, as investors hoped for even better numbers.
How Will the Economy Do as We Head into Q4?
Ayako Yoshioka, Senior Portfolio Manager at Wealth Enhancement Group, discusses how data is indicating how the economy will fare in the fourth quarter of 2024.
Bite Delivers AI-Powered Kiosks To Diners
Brandon Barton, CEO of Bite, explains why the company's self-ordering kiosks are taking over restaurants across the country
